June 30, 2020 / 11:20 AM / 12 days ago

BRIEF-Synthetic Biologics Announces Submission Of Ind Application To U.S. FDA For Syn-020 Intestinal Alkaline Phosphatase

June 30 (Reuters) - Synthetic Biologics Inc:

* SYNTHETIC BIOLOGICS ANNOUNCES SUBMISSION OF IND APPLICATION TO U.S. FDA FOR SYN-020 INTESTINAL ALKALINE PHOSPHATASE

* SYNTHETIC BIOLOGICS INC - INITIAL INDICATION WILL SEEK TO REDUCE ACUTE INTESTINAL SIDE EFFECTS ASSOCIATED WITH RADIATION THERAPY IN CANCER PATIENTS

* SYNTHETIC BIOLOGICS - IND APPLICATION SUPPORTS AN INITIAL INDICATION OF SYN-020 FOR TREATMENT OF RADIATION ENTEROPATHY SECONDARY TO PELVIC CANCER THERAPY

* SYNTHETIC BIOLOGICS INC - INTENDS TO CONDUCT A PHASE 1 SINGLE ASCENDING DOSE STUDY IN HEALTHY VOLUNTEERS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below